1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 18, 1997 (December 15, 1997) Commission File No. 0-11772 NU-TECH BIO-MED, INC. ------------------------- (Exact name of registrant as specified in its charter) Delaware 25-1411971 -------------- ---------------- (State or other jurisdiction of IRS Employer Identification No. incorporation of organization) 476 Main Street, Suite 3-DFL, Wakefield, Rhode Island 02879 - ----------------------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (401) 789-9995 55 Access Road, Suite 700, Warwick, Rhode Island 02886 ------------------------------------------------------ (Former name or former address, if changed since last report.) Page 1 of 3 2 ITEM 5. OTHER EVENTS Effective December 15, 1997, the Registrant is relocating its principal executive offices. The Registrant's principal executive offices will now be located at 476 Main Street, Suite 3-DFL, Wakefield, Rhode Island 02879. The Registrant's new telephone number, effective December 15, 1997, is (401) 789-9995 and fax number is (401) 789-9934. Page 2 of 3 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report on form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. NU-TECH BIO-MED, INC. By: /s/ J. Marvin Feigenbaum --------------------------- J. Marvin Feigenbaum Chairman of the Board President, Chief Executive and Chief Financial Officer Dated: December 18, 1997 Page 3 of 3